Skip to main content
Terug
Watch Compare

GeoVax Labs, Inc.

Datakwaliteit: 83%
GOVX
Nasdaq Manufacturing Chemicals
€ 1,16
▼ € 0,02 (-1,69%)
Marktkapitalisatie: 2,58 M
Prijs
€ 1,16
Marktkapitalisatie
2,58 M
Dagbereik
€ 1,14 — € 1,20
52-Weeksbereik
€ 1,14 — € 34,75
Volume
61.970
Openen € 1,19
50D / 200D Gem.
€ 1,93
39,87% below
50D / 200D Gem.
€ 10,78
89,24% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -24,29 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-654,97%
Onder sectorgemiddelde (-51,02%)
ROIC-522,18%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio3,57
Interest CoverageN/A

Waardering

PE (TTM)
-0,10
Boven sectorgemiddelde (-1,98)
P/B Ratio0,53
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -0,1 -2,0
P/B 0,5 5,1
ROE % -655,0 -51,0
Net Margin % -150,2
Rev Growth 5Y % 9,3
D/E 0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -25,31 M
ROE -654,97% ROA -418,97%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -24,29 M
ROIC -522,18% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,57
Interest Coverage N/A Asset Turnover N/A
Working Capital 4,69 M Tangible Book Value 4,91 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,10 Forward P/E N/A
P/B Ratio 0,53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -941,84%
Market Cap 2,58 M Enterprise Value -2,43 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -10,93 OCF / Share -10,91
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 95,99%
SBC-Adj. FCF -25,29 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue
Net Income -24,99 M -25,97 M -14,02 M -18,57 M -2,96 M
EPS (Diluted)
Gross Profit
Operating Income -25,14 M -26,74 M -14,03 M -18,75 M -2,82 M
EBITDA
R&D Expenses 23,71 M 20,72 M 9,12 M 15,55 M 2,44 M
SG&A Expenses
D&A 95.368,0 74.169,0 56.284,0 38.521,0 19.656,0
Interest Expense 21.375,0 0,0 1.286,0 143.524,0
Income Tax 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8,16 M 9,28 M 31,35 M 11,80 M 10,39 M
Total Liabilities 4,75 M 7,44 M 825.047,0
Shareholders' Equity 5,05 M 5,76 M 26,60 M 4,36 M 9,57 M
Total Debt
Cash & Equivalents 5,51 M 6,45 M 27,61 M 11,42 M 9,88 M
Current Assets 7,93 M 7,89 M 28,94 M 11,63 M 10,24 M
Current Liabilities 3,11 M 3,52 M 4,75 M 5,44 M 810.309,0